For thresholds below 10% (i.e., one patient with PO-AKI for every 10 patients receiving surgery), the net benefits were comparable for the multiple variable model, but were higher than the SPARK and GS-AKI indexes either with or without NT-proBNP. This evidence concerns the gene NPPB and acute kidney injury.